Skip to main content
. 2020 Oct;12(10):5485–5494. doi: 10.21037/jtd-20-2043

Table 2. Development of Zurich Donor Score based on estimated β-coefficients from multiple Cox model and shrinked coefficients.

Predictor N HR (95% CI) β Shrinked β Score points Zurich donor score (total 17 points)
Significant pulmonary infection*
   Yes 127 1.46 (1.14–1.87) 0.38 0.31 3
   No 327 0
Diabetes mellitus
   Yes 25 1.29 (0.80–2.10) 0.25 0.21 2
   No 429 0
PaO2/FiO2-ratio (mmHg)
   >300 278 0
   300 to >150 134 1.30 (1.01–1.66) 0.26 0.21 2
   ≤150 42 1.50 (1.22–1.87) 0.4 0.33 3
Smoking history (pack years)
   <20 377 0
   20 to <50 69 1.43 (0.60–3.50) 0.36 0.29 3
   ≥50 8 1.63 (1.22–2.18) 0.49 0.4 4
Age (years)
   <50 273 0
   50 to <70 151 1.31 (1.02–1.68) 0.27 0.22 2
   ≥70 30 2.24 (1.44–3.50) 0.81 0.66 5

β, β-coefficient; CI, confidence interval; HR, hazard ratio. *Radiological suspicion of pneumonia, bronchoscopic sign of severe bronchitis, history of aspiration (radiological suspicion of pneumonia: opacity in one or more lobes not predominantly resembling in morphology to atelectasis or edema; Signs of severe bronchitis: purulent secretions and/or signs of bronchial inflammation in bronchoscopy; History of aspiration: observed aspiration, signs in bronchoscopy of aspiration or a history highly suspicious of aspiration).